数学建模识别了凝血因子组合,这些组合在正常和因子VIII,IX或XI缺乏血液中修改了血栓生成
Michael T Stobb1, Keith B Neeves2, Dougald M Monroe3
1Department of Mathematics, Coe College, Cedar Rapids, Iowa, USA.
Research and practice in thrombosis and haemostasis
|October 22, 2024
概括
血液凝固蛋白水平的自然变化显著影响了血栓生成. 这些蛋白质变异可以解释因子缺陷中的各种出血表型,指导新的血液静止疗法.
科学领域:
- 血液学 血液学 血液学
- 生物物理学的生物物理.
- 计算生物学 计算生物学
背景情况:
- 凝血蛋白质的血水平与健康个体的平均值自然而然地波动50-150%.
- 这些生理变异对血栓生成的影响在很大程度上仍然未知.
研究的目的:
- 研究凝血蛋白水平正常变化的对模拟血栓生成的影响.
- 在正常血液和因子VIII (FVIII),FIX和FXI缺乏的模型中分析这些影响.
主要方法:
- 运用了流中介凝固的数学模型.
- 模拟探索了所有可能的凝固蛋白变异组合在正常范围内.
- 分析的重点是增强不同组织因子水平的血栓生成的组合.
主要成果:
- 蛋白质变异在中间组织因子水平上最显著地影响了血栓生成.
- 低水平的V因子 (FV) 加快了血栓生成,而高水平则减缓了它.
- 在缺陷时,组织因子通路抑制剂 (TFPI) 和抗血素的变化调节了FV的作用;高FVIII和FIX在正常和FXI缺陷血液中增加了血素生成.
结论:
- 数学建模预测了正常的凝血蛋白变异如何导致因子缺乏的出血表型变异性.
- 该研究产生了可测试的假设,用于开发新型疗法以使血液静止正常化.
更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
Clot Retraction and Fibrinolysis
4.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.4K
Extrinsic and Intrinsic Pathways of Hemostasis
5.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.9K
Disorders of Hemostasis
726
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
726
Coagulation
5.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.1K
Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2


